Remove 2022 Remove Imaging Remove Nuclear Medicine Remove Radiation Oncology
article thumbnail

IMV: PET scan volumes continue to grow

AuntMinnie

In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% from 1,401 estimated PET scans per system in 2022 to 1,495 in 2023. Want to share your knowledge of medical imaging? Want to share your knowledge of medical imaging? physicians reading PET scans per site.

PET Scan 116
article thumbnail

The rise of theranostics: Part 2 -- Moving into communities

AuntMinnie

Even if some private urology, radiation oncology practices, or radiologist groups are building the ability to perform theranostics, experts are cautious about patient management, radiation safety, and the risk of unnecessary imaging. However, few freestanding theranostics centers exist today. Hope added.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

ACR responds to CMS proposed 2025 MPFS rule

AuntMinnie

The organization noted that the CMS expects the overall impact of the proposed MPFS to be neutral on radiology, nuclear medicine, and radiation oncology. Centers for Medicare and Medicaid Services (CMS) proposed Medicare Physician Fee Schedule (MPFS) 2025 rule. However, interventional radiology will have a decrease of 2%.

Medicare 105
article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

FAPI-PET shows promise in head and neck cancer patients

AuntMinnie

In a comparative imaging trial, fibroblast activation protein inhibitor (FAPI)-PET/CT outperformed FDG-PET/CT in detecting primary tumors in patients with head and neck cancer, according to a study published January 25 in the Journal of Nuclear Medicine. PET/CT and MR images of a 72-year-old woman. (A)

article thumbnail

The rise of theranostics: Part 1 -- Gaining momentum

AuntMinnie

Theranostics pairs diagnostic biomarkers that can be visualized on nuclear medicine imaging with therapeutic agents that share a specific target in diseased cells or tissues. After binding to the receptor, the drug works by entering the cell allowing radiation to cause damage to the tumor cells.

article thumbnail

NorthStar to end production of Mo-99

AuntMinnie

No shortage is expected of Mo-99’s daughter decay chain isotope technetium-99m (Tc-99m), which is used in an estimated 40,000 diagnostic nuclear medicine exams each day in the U.S., said the Society of Nuclear Medicine and Molecular Imaging (SNMMI). supply of the isotope and help reduce U.S. radiopharmacy market.